Other birth control methods should be considered in the risk/benefit analysis for the use of Depo-Provera CI in women withosteoporosisrisk factors. Depo-Provera CI can pose an additional risk in patients with risk factors for osteoporosis (e.g., metabolic bone disease, chronic alcohol and/or t...
stroke,breast cancer,blood clots, and pulmonary emboli (blood clots that lodge in the lungs) inpostmenopausalwomen (50 to 79 years of age) who took medroxyprogesterone in combination with estrogens for 5 years, as well as an increased risk ofdementiain the women over age 65. Therefore, medrox...
The most common side effects when taking medroxyprogesterone are nausea, stomach upset, abdominal cramps, and temporarily heavy menstrual bleeding. Some women experience drowsiness, insomnia, mild fevers, and high blood pressure. Rarely, the medication can cause swelling and tenderness in the breasts, ...
Depot medroxyprogesterone acetate is one of the most popular, effective methods of contraception used in the United States. Many women experience unpleasant side effects from this method, including episodic vaginal bleeding, hair loss, depression, and weight gain. This Clinical Practice Exchange ...
prevention of endometrial changes in replacement therapy estrogen in postmenopausal women.Contra-Provera: hypersensitivity, thrombophlebitis, thromboembolic syndrome or a history of stroke, liver disease, vaginal bleeding of unspecified etiology, pregnancy, breastfeeding (stop).Side effects: Menstrual irregul...
There have been reports of serious thrombotic events in women using medroxyprogesterone acetate (150 mg). However, medroxyprogesterone acetate has not been causally associated with the induction of thrombotic or thromboembolic disorders. Any patient who develops thrombosis while undergoing therapy with medrox...
Use: Prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets Usual Adult Dose for Abnormal Uterine Bleeding: Oral tablets: -5 or 10 mg daily for 5 to 10 days, beginning on the 16 th or 21 st day of...
Depo-medroxyprogesterone Acetat is a long acting, injectable progesterone derivative contraceptive which is currently used by more than 90 million women worldwide. This contraceptive is suggested to induce changes in lipid profile, body weight and blood pressure among various populations and ethnic group...
A complementary study of this in a Scottish city confirmed that women who had used medroxyprogesterone for at least 5 years (mean 12 years) had a lower bone density than controls, but no new evidence as to the reversibility of the effect was provided (90c). ...
BACKGROUND:Abnormal uterine bleeding (AUB) lowers the quality of life of women. This study attempted to determine which treatment protocol of medroxyprogesterone acetate (MPA), 15 vs 10 day-administration in a luteal phase, provides better outcomes in wo